miR-145 Cancer Research Results
miR-145, miR-145: Click to Expand ⟱
| Source: |
| Type: tumor suppressor miRNA |
miR-145 has been identified as a tumor suppressor miRNA, and its downregulation has been observed in various types of cancer.
|
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
Ovarian, |
SKOV3 |
|
|
|
Warburg↓, berberine inhibited the Warburg effect by up-regulating miR-145, miR-145 targeted HK2 directly.
miR-145↑,
HK2↓, westernblot suggested that berberine could significantly down regulate the expression of HK2
TET3↑, Berberine increased the expression of miR-145 by promoting the expression of TET3 and reducing the methylation level of the promoter region of miR-145 precursor gene.
Glycolysis↓, Furthermore, the effect of berberine on glycolysis related enzymes was detected, the results of qRT-PCR and westernblot suggested that berberine could significantly down regulate the expression of HK2
PKM2↓, Western blot results showed down-expression of miR-145 reversed berberine's inhibition of HK2 expression. PKM2, pyruvate kinase M2; HK2, Hexokinase2; GLUT1, glucose transporter 1; LDH, lactate dehydrogenase; PFK2, phosphofructokinase 2; PDK1,
GLUT1↓,
LDH↓,
PFK2↓,
PDK1↓,
COX2↓, Celecoxib, a selective cyclooxygenase-2 inhibitor
TumCP↓,
TumCMig↓,
TumCI↓,
EMT↓,
miR-145↑,
TGF-β↓,
SMAD3↓,
miR-497↑, Curcumin was found to cause the upregulation of miR-497, miR-200c, miR-200b, miR-409-3p, miR‐34, miR‐126, miR-145, miR-206, miR-491, miR-141, miR-429, miR-101, and miR-15a
miR-200c↑,
miR-409-3p↑,
miR-34a↑,
miR-126↑,
miR-145↑,
miR-206↑,
miR-491↑,
miR-141↑,
miR-429↑,
miR-101↑,
miR-15↑,
miR-21↓, and the downregulation of miR-21, miR-155, miR‐221, miR‐222, miR-17-5p, miR-130a, miR-27, and miR-20a.
miR-155↓,
miR-221↓,
miR‐222↓,
miR-17↓,
miR-130a↓,
miR-27a-3p↓,
miR-20↓,
NOTCH1↓, Furthermore, EGCG suppressed Notch1
BMI1↓,
SUZ12↓,
EZH2↓,
miR-34a↑,
miR-200c↑,
miR-145↑,
CSCs↓, (EGCG), an active catechin present in green tea, has been shown to suppress CSC growth in various cancers
Showing Research Papers: 1 to 4 of 4
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 4
Pathway results for Effect on Cancer / Diseased Cells:
Core Metabolism/Glycolysis ⓘ
Glycolysis↓, 1, HK2↓, 1, LDH↓, 1, PDK1↓, 1, PFK2↓, 1, PKM2↓, 1, Warburg↓, 1,
Cell Death ⓘ
miR-497↑, 1,
Transcription & Epigenetics ⓘ
EZH2↓, 1, miR-145↑, 4, miR-21↓, 1, miR-27a-3p↓, 1, miR-409-3p↑, 1, TET3↑, 1,
Proliferation, Differentiation & Cell State ⓘ
BMI1↓, 1, CSCs↓, 1, EMT↓, 1, miR-101↑, 1, miR-34a↑, 2, miR-429↑, 1, NOTCH1↓, 1, SUZ12↓, 1,
Migration ⓘ
miR-130a↓, 1, miR-141↑, 1, miR-155↓, 1, miR-20↓, 1, miR-200c↑, 2, miR-206↑, 1, miR-221↓, 1, miR-491↑, 1, miR‐222↓, 1, SMAD3↓, 1, TGF-β↓, 1, TumCI↓, 1, TumCMig↓, 1, TumCP↓, 1,
Angiogenesis & Vasculature ⓘ
miR-126↑, 1, miR-15↑, 1, miR-17↓, 1,
Barriers & Transport ⓘ
GLUT1↓, 1,
Immune & Inflammatory Signaling ⓘ
COX2↓, 1,
Clinical Biomarkers ⓘ
EZH2↓, 1, LDH↓, 1, SUZ12↓, 1,
Total Targets: 44
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: miR-145, miR-145
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:839 State#:% Dir#:2
wNotes=on sortOrder:rid,rpid
Home Page